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Lentiviruses are widespread in a variety of verte-
brates, often associated with chronic disease states.
However, until the recent discovery of the prehistoric
endogenous lentiviruses in rabbits (RELIK) and
lemurs (PSIV), it was thought that lentiviruses had
no capacity for germline integration and were only
spread horizontally in an exogenous fashion. The
existence of RELIK and PSIV refuted these ideas,
revealing lentiviruses to be present in a range of
mammals, capable of germline integration, and far
more ancient than previously thought. Using Gag
sequences reconstructed from the remnants of these
prehistoric lentiviruses, we have produced chimeric
lentiviruses capable of infecting nondividing cells
and determined structures of capsid domains from
PSIV and RELIK. We show that the structures from
these diverse viruses are highly similar, containing
features found in modern-day lentiviruses, including
a functional cyclophilin-binding loop. Together,
these data provide evidence for an ancient capsid-
cyclophilin interaction preserved throughout lentivi-
ral evolution.
INTRODUCTION
Throughout evolution, mammalian genomes have been exposed
to invading retroviruses. Moreover, zoonotic transmission has
occurred, typified by the pandemic and epidemic spread of
HIV-1 and HIV-2 from chimpanzees and sooty mangabeys,
respectively. In many cases, proviruses have been incorporated
into the host germline, becoming endogenous retroviruses
(ERVs) capable of vertical transmission. Although integration
into the germline is commonplace in many retroviral genera
and hosts, it was thought that lentiviruses were entirely exoge-
nous, comprising five groups, each infecting a specific mamma-248 Cell Host & Microbe 8, 248–259, September 16, 2010 ª2010 Elslian order (Linial et al., 2005). However, the recent discovery of
two ancient ERVs, rabbit endogenous lentivirus type K (RELIK)
(Katzourakis et al., 2007; Keckesova et al., 2009) and
prosimian immunodeficiency virus (PSIV) from lemurs (Gifford
et al., 2008; Gilbert et al., 2009), revealed that lentiviruses are
more widespread than previously thought, can be incorporated
into the host germline, and are ancient, existing prior to 12million
years ago.
A particular feature of some lentiviruses is their interaction with
cyclophilin A (CypA), a host cell peptidyl proline-isomerase
(PPIase) that is incorporated into virions (Luban et al., 1993; Thali
et al., 1994). HIV-1 particles contain substantial quantities of
CypA (Braaten et al., 1996), and CypA binds to a region on the
amino-terminal domain of the capsid protein (CA-NtD), referred
to as the CypA-binding loop (Gamble et al., 1996). Moreover,
other studies have shown that inhibition of the CypA-CA interac-
tion reduces HIV-1 infectivity in certain cell types (Franke and
Luban, 1996). It has now become apparent that lentiviral CypA
dependence is not confined to HIV-1 and the closely related
SIVcpz, as CypA has been shown to interact with the CA-NtDs
of other lentiviruses, most notably FIV and SIVagm (Lin and
Emerman, 2006) and, to a lesser extent, HIV-2 (Price et al., 2009).
Primates express a variety of evolving cellular factors that act
as postentry restriction factors, blocking lentivirus replication
and preventing integration into the target cell genome. The
most extensively characterized is TRIM5a, first isolated from
rhesus macaques (Stremlau et al., 2004). Subsequently, homo-
logs have been identified in many primates and in other
mammals not known to be lentiviral hosts (Schaller et al., 2007;
Ylinen et al., 2006). TRIM5a proteins comprise a tripartite
RING, B-box, and coiled-coil motif together with a B30.2
domain that determines the CA specificity range of a particular
TRIM5a. However, on at least two separate occasions, retro-
transposition of CypA has resulted in the substitution of the
C-terminal B30.2 domain in the TRIM5a protein, giving rise to
omTRIMCyp, found in Aotus sp., the New World owl monkey
(Nisole et al., 2004; Sayah et al., 2004), and rhTRIMCyp, found
in old world rhesus, crab-eating, and pigtailed macaques (New-
man et al., 2008; Virgen et al., 2008; Wilson et al., 2008). The
precise details of TRIM5a- and TRIMCyp-mediated restrictionevier Inc.
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Figure 1. Composition and Infectivity of Chimeric Retroviruses
(A) SDS-PAGE analysis of retroviral particles. Lane 1, mock transfection; lanes
2–4, EIAV-RELIK, EIAV-PSIV, and EIAV. Sizes of marker proteins are indicated
on the left (kDa); bands corresponding to the sizes of viral components are
indicated on the right.
(B) Titers of lacZ-EIAV, lacZ-EIAV-RELIK, and lacZ-EIAV-PSIV in CrFK, D17,
SIRC, or HT1080 cell lines. The histogram shows the number of lacZ-forming
units per milliliter for each virus supernatant in the different cell types. In each
case, the plotted value is from the average of two independent experiments,
and error bars represent themeanmeasurement ± the standard deviation (SD).
(C) Titers of MLV, EIAV, EIAV-RELIK, and EIAV-PSIV in control and aphidicolin-
treated D17 cells. Viral titers were determined as in (B).
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Structure of the RELIK-CypA Complexremain uncharacterized, but various mechanisms have been
proposed, including accelerated uncoating of the incoming viral
core, targeted proteasomal degradation of CA, and blocking of
the formation or transport to the nucleus of the viral integration
complex (Chatterji et al., 2006; Perron et al., 2007; Rold and
Aiken, 2008; Wu et al., 2006; Yap et al., 2006). The common
feature of these ideas is that TRIM5a and TRIMCyp act by target-
ing the viral CA protein in the context of the subviral capsid core
(Wolf and Goff, 2008).
Presently, the origin and function of the CA-CypA interaction
and whether it is a feature exclusive to modern lentiviruses is
unclear. Here, we report the crystal structures of the CA-NtD
from the two ancient ERVs, PSIV and RELIK, together with that
of a RELIK-CypA complex. Remarkably, the structures of these
ancient capsids are largely conserved with those of modern
exogenous lentiviruses and can function in the context of a
chimeric virus, producing infectious viral particles that incorpo-
rate CypA. Our structural studies demonstrate that although
the mode of CypA binding is similar to HIV, the positioning of
CypA on the RELIK CA is somewhat different, allowing
secondary interactions to accompany the main CypA-binding
loop interaction. Furthermore, we show that introduction of the
CA of these ancient viruses into equine infectious anemia virus
(EIAV) chimeras renders the normally resistant EIAV susceptible
to the cellular restriction factors omTRIMCyp and rhTRIMCyp.
These data reveal that the CypA-CA interaction is not limited
to HIV and is likely a widespread feature, characteristic of the
lentiviral family. Moreover, the cyclophilin-CA interaction is
ancient, predating the existence of HIV by at least 12 million
years, and we note that the emergence of TRIMCyp restriction
factors in the new and old world monkey lineages occurred
around 4–20 million years ago. These data provide evidence
for the existence and cyclophilin dependence of ancient retrovi-
ruses and for an antagonistic relationship between ancient
lentiviruses and cellular restriction factors during the Miocene
and Pliocene ages.
RESULTS
The Capsids of Ancient Lentiviruses Are Incorporated
into Infectious Mature Virions
To investigate if the reconstructed endogenous lentiviral
sequences encode functional proteins, regions encoding the
CA protein of RELIK and PSIV were substituted for that of
EIAV, and these chimeric constructs were tested for their ability
to produce infectious virions. In both constructs, the first four
N-terminal residues and last five C-terminal residues of the
EIAV CA were preserved to maintain the sequences flanking
the cleavage sites that are recognized by the EIAV protease.
Chimeric Gag-Pol constructs were transfected into 293T cells
together with a plasmid expressing the vesicular stomatitis virus
envelope protein (VSV-G) and an EIAV vector encoding the GFP
and lacZ reporter genes. Forty-eight hours posttransfection,
virions were purified from the cell supernatant and analyzed by
SDS-PAGE (Figure 1A). Proteins with molecular weights corre-
sponding to the matrix (MA) and nucleocapsid (NC) of EIAV
were detected in virion preparations from cells transfected with
Gag-Pol of EIAV and that of chimeric EIAV-RELIK and EIAV-
PSIV, but not from the supernatants of nontransfected cells. InCell Host &addition, bands of slightly different sizes corresponding to the
CA of EIAV, RELIK, and PSIV were also observed, indicating
that correctly processed CA was present in these viruses.
These data reveal that the ancient lentiviral capsids are func-
tional during the late stages of the viral life cycle. To test whetherMicrobe 8, 248–259, September 16, 2010 ª2010 Elsevier Inc. 249
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Figure 2. Structures of Ancient Retroviral
Capsids
(A and B) Crystal structures of CA amino-terminal
domains from RELIK (A) and PSIV (B). Orthogonal
cartoon representations of each molecule are
shown, the N and C termini are indicated, and
a helices and b strands are numbered. See also
Figure S1.
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Structure of the RELIK-CypA Complexchimeric viruses are able to support early life-cycle events, the
infectivity of virus recovered from transfected cells was assayed
using a panel of feline (CrFK), canine (D17), lagomorph (SIRC),
and human (HT1080) cell lines. Infectivity was quantified by
staining the cells for lacZ expression (Figure 1B). Using this
assay, chimeric viruses yielded titers that were between 104
and 105 lacZ-forming units per milliliter in CrFK cells and slightly
less in D17 cells. The EIAV-RELIK titers were 10-fold lower in
HT1080 cells and almost 100-fold lower in SIRC cells, while
the EIAV-PSIV titers were 100- and 1000-fold lower in these
cell lines, respectively. Consequently, further infectivity assays
were carried out in the D17 and CrFK cell lines. To test whether
the PSIV and RELIK CA could also support infection of nondi-
viding cells, a characteristic exclusive to lentiviruses (Lee et al.,
2010), an infection assay was conducted in D17 cells, arrested
in S-phase by aphidicolin treatment (Figure 1C). The EIAV,
EIAV-RELIK, and EIAV-PSIV titers are not reduced by growth
arrest, whereas the titer of MLV is reduced 1000-fold in the
arrested cells. These results demonstrate that the ancient lenti-
viral CAs were capable of providing the capsid functions,
including the capacity to infect nondividing cells, that are
required for viral entry during the early phase of the viral life cycle.
Structures of RELIK and PSIV CA-NtDs
The crystal structures of the CA-NtDs from PSIV and RELIK are
presented in Figure 2, and details of the structure solution are
presented in Table S1. These structures are representative of
two diverse ancient lentiviral capsids that existed more than
12 million years ago. However, they are remarkably similar to250 Cell Host & Microbe 8, 248–259, September 16, 2010 ª2010 Elsevier Inc.each other, with an overall rmsd of only
1.3 A˚ in the Ca positions for residues in
secondary structure elements. Both
structures contain the familiar arrange-
ment of secondary structure elements
observed in the N-terminal domains of
CAs from modern retroviral genera,
comprising a short b hairpin followed by
a five a helix core made up from a1, a2,
a3, a4, and a6. A highly ordered N-terminal
b hairpin, a feature of present-day retro-
viral maturation, is also apparent. In
RELIK, it is stabilized by a conserved
salt bridge between the imino terminus
of Pro1 and the carboxylate of Asp51
and by hydrogen bonds with surrounding
residues, specifically between Asp51 and
the hydroxyl of Tyr11 and between Pro1
and the backbone carboxylate of Glu12
(Figure S1A). In the PSIV structure, theN-terminal b hairpin is formed by a salt bridge between Pro1
and Glu51 where the orientation of Glu51 is maintained through
a hydrogen bond with the backbone amide of Ser48. However,
although a conserved aromatic Tyr11 is also present, unlike
RELIK, it does not form a direct interaction with Glu51 but
instead is coordinated by a water molecule (Figure S1B). A
further notable feature of the PSIV structure is an interaction
between the b2 and a6 structural elements that is not observed
in other lentiviral CA-NtD structures. In this instance, the b2
strand is drawn toward the top of a6 by a p-electron stacking
interaction between the side chain of Trp9 and the guanidine
moiety of Arg111. Whether this has any functional consequence
is unclear. The remaining differences between the RELIK and
PSIV structures are confined to the region joining a4 to a6, the
equivalent of the HIV-1 cyclophilin-binding loop. In RELIK, this
region is much longer, consisting of a large 15-residue extended
loop containing a cis Gly93-Pro94 dipeptide linkage followed by
two short single-turn helices, a5 and a50. In PSIV, a5 and a50 are
also present, but the preceding loop is shorter, only nine
residues in length, and does not contain a Gly-Pro dipeptide.
The large Gly-Pro-containing loop in RELIK is reminiscent of
the CypA-binding loop of HIV-1, and Figure 3A shows an overlap
of ancient andmodern lentiviral CA-NtDs, with a structure-based
sequence alignment shown in Figure 3B. Overall, ancient and
modern structures are strongly conserved. However, there are
major structural and sequence differences apparent throughout
the CypA-binding loop that is highly variable in composition,
length, and conformation. Bearing these overall structural simi-
larities in mind, the phylogenetic relatedness of capsids from
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Figure 3. Structural and Sequence Align-
ment of Retroviral Capsids
(A) Structural superimposition of CA-NtD from
RELIK (blue), PSIV (wheat), and HIV-1 (magenta).
Molecules are oriented as in Figure 2.
(B) Structure-based sequence alignment of the
CA-NtDs from RELIK, PSIV, HIV-1, and HIV-2.
The positions of RELIK secondary structure
elements are indicated above the alignment. Resi-
dues conserved in all sequences are highlighted in
dark gray. Residues conserved in a minimum of
three sequences are boxed in light gray.
(C) Phylogenetic tree based on the rmsd of main-
chain atoms for retroviral CA-NtDs. Four divergent
branches are apparent, corresponding to the
delta, gamma, alpha-beta, and lentiviral genera.
PDB codes of previously determined structures
used in the analysis are indicated. The resolution
of the X-ray structures used in this analysis range
from 1.5 to 2.7 A˚, with associated coordinate
errors of 0.2–0.4 A˚. The rmsds of structural align-
ments range from 1.5 to 3.0 A˚ between members
of the same genera and from 4 to 8 A˚ between
structures from different genera.
Cell Host & Microbe
Structure of the RELIK-CypA Complexprehistoric RELIK and PSIV with other modern retroviral capsids
and other retroviral genera was examined using the SAP
program (Taylor, 1999).
Despite the high degree of primary sequence divergence
(>75%), the strong structural similarities permit construction of
ameaningful dendrogram based on rmsd of all Ca positions (Fig-
ure 3C). On inspection of the rmsd-derived phylogenetic tree, the
CA-NtDs from different retroviruses cluster into four groups,
consistent with previously defined genera. The only exception
is the inclusion of the alpharetrovirus RSV in the betaretrovirus
group, which has been noted previously (Mortuza et al., 2009).
The CA-NtDs of RELIK and PSIV group within themodern lentivi-
ruses, RELIK being more similar to PSIV than it is to EIAV (rmsd,
2.4 A˚ and 3.1 A˚). The lemur retrovirus PSIV falls between RELIK
and theprimate retroviruses, but given theuncertainty in equating
rmsd with evolutionary relationship, it is possible that either PSIV
or RELIK could be the closer relative of the HIV viruses. However,
both RELIK and HIV contain the large Gly-Pro-containing cyclo-
philin-binding loop in their variable a4-a6 regions that is absent
from PSIV. This suggests that in a common RELIK-HIV-PSIV
progenitor, the large Gly-Pro Cyp loop was present and was
lost when PSIV separated or that selective pressure not encoun-
tered by PSIV drove the evolution of the large Gly-Pro loop in
RELIK and HIV on separate occasions. Nevertheless, it appears
that in some ancient retroviruses, selective pressure to retain
a large cyclophilin-binding loop was apparent, whereas under
other conditions the loss of the Cyp loop was tolerated.
CypA Is Incorporated into VirionsContaining theAncient
Lentiviral CA
In the RELIK crystal, the Gly93-Pro94 dipeptide in the region
analogous to the HIV-1 CypA-binding loop adopts a cis confor-
mation, albeit stabilized by crystal contacts with a symmetry-
related molecule (Figure S2). Moreover, it has been shown that
the CA-NtDs of HIV-1 and FIV have CypA binding activity. The
structural conservation we observe, together with the presence
of the RELIK cis-proline, prompted us to examine if a similarCell Host &interaction took place between CypA and the CA from ancient
lentiviruses by testing for the incorporation of CypA into viral
particles. SIVmac, EIAV, EIAV-RELIK, and EIAV-PSIV viruses
were purified from transfected cells, and the degree of CypA
incorporation was assessed by western blotting with anti-CypA
antibodies (Figure 4A). As all the virions were pseudotyped
with VSV-G, filters were also probed with an anti-VSV-G anti-
body to normalize viral protein loading. A small amount of
CypA appeared to be incorporated into EIAV, possibly due to
contaminating vesicle-associated CypA (Braaten et al., 1996),
even though very little or none was found in SIVmac. In contrast,
significant quantities of CypA were detected in the EIAV
chimeras that contained both the RELIK and the PSIV capsids,
revealing that the capsids from ancient lentiviruses associate
with CypA and that these viruses likely incorporate CypA through
this interaction.
In Vitro Analysis of CA-CypA Interactions
To further characterize CA-CypA binding and to confirm the
validity of the virological data, the affinity of the interaction of
CypA with the CA-NtD of RELIK was investigated using
isothermal titration calorimetry (ITC). A typical thermogram along
with a comparative titration employing HIV-1 CA-NtD is shown in
Figure 4B. In both cases, the interaction is exothermic at 20C,
with a negative enthalpic contribution of 6.9 (RELIK) and
8.9 (HIV-1) kcal.mol1. The equilibrium association constants
(KA) obtained by fitting these calorimetric data are in the order
of 105 M1, where the RELIK-CypA association is around
3-fold weaker than the HIV-CypA interaction, corresponding to
a 0.7 kcal.mol1 difference in the free energy of formation of
the HIV-CypA and RELIK-CypA complexes (see Figure 4D).
This modest difference in binding energy reveals that even
though the Cyp loop sequences differ, HAGPIAP in HIV and
AAGPVPL in RELIK, CypA is able to accommodate either without
a large energetic penalty.
The interaction of CypAwith the lentiviral capsids of PSIV, HIV,
and FIV, together with that of B-tropic MLV, was alsoMicrobe 8, 248–259, September 16, 2010 ª2010 Elsevier Inc. 251
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Figure 4. Analysis of CA-CypA Interactions
(A) Incorporation of CypA by SIVmac, EIAV, EIAV-RELIK, and EIAV-PSIV, analyzed by western blotting. The virus tested is shown above each lane; signals
corresponding to VSV-G and CypA are indicated on the right.
(B) The interaction of CypA with the CA-NtD of RELIK (left) and HIV-1 (right) quantified by ITC. Top panels are raw thermograms, and the bottom panels show the
titration data along with line of best fit and the fitted parameters (inset).
(C) The interaction of CypA with the CA-NtD of PSIV, HIV-1, FIV, and MLV, analyzed by SPR. See also Figure S3. The binding isotherms were constructed from
the average sensorgram plateau values measured at increasing CA-NtD analyte concentration (0.01–1 mM). The error bars represent the mean ± SD of three
independent measurements.
(D) Summary of Biacore and ITC binding data.
Cell Host & Microbe
Structure of the RELIK-CypA Complexinvestigated using Biacore surface plasmon resonance (SPR).
Here, biotin-labeled CypA was immobilized on the surface of
a streptavidin-coated sensor chip, and increasing concentra-
tions of CA-NtD analytes were applied under flow. The results
of these titrations are presented in Figure 4C and tabulated in
Figure 4D. The raw sensorgrams are presented in Figure S3. It
is clear that all the lentiviral capsids, including PSIV, bind to
CypA, whereas there is no measurable interaction with the
B-MLV negative control. Furthermore, under these conditions
the apparent affinity for the HIV- and PSIV-CypA interaction is
very similar, 3–4 3 104 M1. These data confirm that as is the
case with RELIK, the capsid from this second ancient retrovirus
can also bind to CypA. Inspection of these data also reveals that
the CA-NtD from the nonprimate lentivirus FIV also binds to
CypA, although the interaction is somewhat weaker than with
either HIV or PSIV.
These binding data demonstrate that the CA-NtDs of PSIV and
RELIK associate with CypAwith affinities comparable to those of
modern-day mammalian and primate lentiviruses. Moreover,
they provide a rank order for the interaction of CypA with
different capsid molecules. The CA-NtDs from HIV-1, PSIV,252 Cell Host & Microbe 8, 248–259, September 16, 2010 ª2010 Elsand RELIK bind with similar affinity, FIV is weaker, and the inter-
action with the CA-NtD of the gammaretrovirus B-MLV is unde-
tectable, presumably because the CypA-binding loop is entirely
absent (Mortuza et al., 2004). Notably, the binding to FIV CA-NtD
appears significantly weaker than HIV-1, PSIV, and RELIK.
However, it has been proposed that the mode of interaction of
CypA with the FIV CA-NtD involves a Arg-Pro rather than
a Gly-Pro linkage (Lin and Emerman, 2006), so it is possible
this difference in affinity reflects a change in the mode of the
CypA-CA interaction. Interestingly, in PSIV, Gly-Pro linkages
are also absent from the a4-a6 loop; however, both Gln86-
Pro87 and Leu88-Pro89 dipeptides are present. While it is
unclear if either Gln-Pro or Leu-Pro or both constitute CypA
binding sites, taking into account the Arg-Pro dipeptide in FIV,
it seems that CypA can utilize different binding modes, having
the capacity and adaptability to accommodate dipeptides other
than Gly-Pro present in CA a4-a6 loops.
Structure of the CypA-RELIK Complex
Our in vivo and in vitro analyses of ancient CA-CypA interactions
convincingly demonstrate hetero-association of the CA-NtD ofevier Inc.
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Figure 5. Structure of the RELIK-CypA
Complex
(A) Crystal structure of the RELIK CA-NtD-CypA
with RELIK in blue and CypA in green. The orienta-
tion of the RELIK CA-NtD is as in Figure 1.
(B) Details of the RELIK-CypA molecular interface.
Residues 91–96 of RELIK CA-NtD are shown as
sticks (blue) located in the CypA binding groove;
Pro94 is indicated. CypA is shown in green; resi-
dues that make hydrogen-bonding interactions
(dashed lines) are labeled and displayed as sticks.
(C) Details of trans (left panel) and cis (right panel)
HIV-CypA molecular interfaces. The HIV-1 Cyp-
binding loops are shown as sticks (magenta) in
the binding groove of CypA; the isomeric Pro90
is indicated in each panel. The orientation of
CypA and residues involved in hydrogen bonds
are displayed as in (B). See also Figure S4.
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of this heterodimer, we determined the structure of a RELIK
CA-NtD-CypA complex. Details of the structure solution are
presented in Table S1. In the complex (Figure 5A), the overall
conformation of RELIK is essentially the same as in the free
structure, except for a large 10–12 A˚ displacement of the a4-a6
cyclophilin-binding loop (Figure S4). CypA adopts the same
conformation that has been observed in other X-ray structures
(Kallen et al., 1991; Ke et al., 1993), comprising an eight-stranded
b barrel and two a helices that cap each end. One side of the
barrel forms a concave surface made of b3, b4, b6, and b5 and
contains a hydrophobic peptide binding groove containing the
proline-isomerase active site of the molecule. Residues Ala91-
Pro96 of the RELIK cyclophilin-binding loop are located within
the binding groove of CypA and make extensive hydrophobic
interactions together with main chain-mediated polar contacts
at the interface (Figure 5B). Within the groove, Pro94 adopts
a cis configuration positioned adjacent to His126 of CypA
(cypHis126) in the hydrophobic pocket that constitutes the
CypA active site. The key catalytic arginine, cypArg55, is located
on the opposing side of the pocket from cypHis126, sandwiching
Pro94 and hydrogen bonding to its main-chain carbonyl. This
orientation positions the cypArg55 guanidine side chain in close
proximity, 3.5 A˚ from the proline imino group, and facilitates
stabilization of the proline nitrogen during catalysis (Howard
et al., 2003). The active site configuration is further stabilized
through hydrogen bonding of the carbonyl group of the Gly93-
Pro94 cis peptide with the amide side chain of cypGln63 and by
hydrogen bonds between the amide of Gly93 and themain-chain
carbonyl of cypAsn102. The carbonyl of Val95 also contributes toCell Host & Microbe 8, 248–259, Sethe interface through interaction with the
N31 of the
cypTrp121 ring.
A comparison of the RELIK- with the
HIV-1-CypA cis and trans proline inter-
faces (Gamble et al., 1996; Howard
et al., 2003) (Figure 5C) reveals that
despite sequence and isomeric configu-
ration differences, the backbone trajec-
tory of the cyclophilin-binding loop and
interactions with the hydrophobic grooveon the surface of CypA are structurally conserved. Inspection of
the HIV-1 and RELIK-CypA complexes reveals that the side
chain orientation and hydrogen bonding contributions from
cypTrp121, cypHis126, cypGly72, and cypAsn102 are maintained.
Moreover, regardless of isomeric configuration, the Gly-Pro
dipeptide is oriented in the same manner to allow coordination
of the proline carbonyl by the catalytic cypArg55. However,
although the detailed organization of the active site is a strongly
conserved feature of the RELIK and HIV heterodimers, the
complexes differ significantly in respect to the orientation of
CypA relative to the RELIK and HIV-1 CA-NtDs. In the RELIK
complex, CypA is rotated 90 about the cyclophilin-binding
loop compared to the orientation observed in the HIV-1 struc-
ture. Furthermore, the bound Gly-Pro dipeptide in RELIK is
permuted five residues C-terminal to the Gly-Pro dipeptide in
HIV-1 (Figure 6A). This rotation, combined with the shifted site
position, brings CypA closer to the core of the RELIK NtD than
in the CypA-HIV complex. Consequently, the RELIK-CypA inter-
face comprises a larger buried surface, 792 A˚2 compared to
505 A˚2 in HIV, and additionally, it facilitates specific interactions
between CypA and residues at the termini of the RELIK a4 and a6
that are absent in the HIV-1 complex. The details of these
secondary RELIK-CypA binding sites are shown in Figures 6B
and 6C. Secondary site I is at the carboxy terminus of RELIK
a4 and consists of a hydrogen-bonding interaction between
the backbone carbonyl of Met83 and the guanidinium moiety
of cypArg148 in the CypA a2-b8 loop. Secondary site II is at the
amino terminus of a6 and is more extensive, incorporating the
loop between a50 and a6 of RELIK and the loop between b6 and
b7 of CypA. Here, the side chain of
cypGlu120 interacts with theptember 16, 2010 ª2010 Elsevier Inc. 253
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Figure 6. Features of the CypA-RELIK and
CypA-HIV-1 Complexes
(A) The position of CypA in the HIV-1 complex is
rotated90 with respect to the RELIK complex.
The CypA-RELIK (left) and CypA-HIV-1 (right)
complexes have been structurally aligned on the
CA-NtD molecules, shown in the background in
silver. The CypA-binding loops are highlighted as
sticks in blue (RELIK) and magenta (HIV-1). CypA
is displayed in the foreground in green.
(B and C) Residues involved in secondary-site
interactions at the carboxy terminus of RELIK a4
(B) and the amino terminus of RELIK a6 (C). RELIK
is shown in blue and CypA in green. Residues that
mediate secondary-site interactions are labeled
and shown as sticks; dashed lines represent
hydrogen-bonding interactions.
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Structure of the RELIK-CypA Complexdipole of the RELIK a6 through hydrogen bonding to the main-
chain amide group of Asp119, and Arg116 in the loop between
a50 and a6 interacts with the main-chain carbonyl of
cypTrp121.
Although it should be noted that these secondary sites do not
make up a large proportion of the buried surface at the RELIK-
CypA interface, their existence reveals the potential for regions
of CypA other than the active site to be involved in substrate/
target recognition.
EIAV-RELIK and EIAV-PSIV Are Restricted
by TRIMCyp Factors
The discovery of omTRIMCyp and rhTRIMCyp that restrict HIV-1
and HIV-2, respectively, has demonstrated that CypA is utilized
naturally as a CA-binding domain in the context of a restriction
factor. The incorporation of CypA into the chimeric RELIK-EIAV
and PSIV-EIAV viruses, together with our biophysical and
structural data, prompted us to test whether the CA-NtD of
RELIK and PSIV might be targeted by these present-day
TRIMCyp restriction factors. HIV-1 and EIAV together with
RELIK-EIAV and PSIV-EIAV viruses carrying lacZ reporter genes
were used to infect CrFK cells that had been transduced with
either omTRIMCyp or rhTRIMCyp (Figure 7). In this assay, EIAV254 Cell Host & Microbe 8, 248–259, September 16, 2010 ª2010 Elsevier Inc.infects control and transduced cells at a
similar titer (1 3 107 infectious units
per milliliter) regardless of the presence
of either TRIMCyp factor. These data
demonstrate conclusively that EIAV is
not restricted by either omTRIMCyp or
rhTRIMCyp. In contrast, the titers of
EIAV-RELIK and EIAV-PSIV are reduced
100-fold compared to control cells
when either omTRIMCyp or rhTRIMCyp
is expressed. At the same time, HIV-1
titers are reduced 100-fold and
10-fold, respectively. These data reveal
that replacement of EIAV CA with CA of
either ancient retrovirus confers restric-
tion sensitivity so that either TRIMCyp
efficiently restricts both chimeric viruses.
These data are consistent with our CypA
binding and structural data and showthat the EIAV-RELIK and EIAV-PSIV chimeras not only bind
monomeric CypA but can also form viral cores with a configura-
tion efficiently recognized by multimeric restriction factors.
DISCUSSION
Ancient Capsid Structures and CypA Binding
The discovery that lentiviruses invaded and colonized mamma-
lian genomes in the late Miocene and Pliocene periods
4–12 million years ago (Gilbert et al., 2009; Katzourakis et al.,
2007) prompted us to investigate whether structural features of
modern-day lentiviruses were present in these ancient ances-
tors. To answer this question, we determined the structure of
the CA-NtD from the prehistoric ERVs, RELIK and PSIV. Remark-
ably, despite low sequence homology, the RELIK and PSIV
structures are highly similar to those of modern-day exogenous
lentiviruses. Our comparison of the RELIK CA-NtD with that of
HIV-1 reveals an rmsd of only 1.5 A˚ over the core NtD fold,
with sequence identity of 27%. Moreover, we found that RELIK
not only contains the cyclophilin-binding loop that is present in
modern exogenous lentiviruses but maintains the capacity to
form a protein-protein complex with CypA. These observations
Figure 7. Restriction of the RELIK and PSIV Chimeric Viruses
LacZ-EIAV, -HIV-1, -EIAV-RELIK, and -EIAV-PSIV viruses were used to
challenge control CrFK cells and CrFK cells expressing TRIMCyp from either
owl monkey or pig-tailed macaque. The viral titers in control and transduced
cells were then determined by staining for b-galactosidase activity and cell
counting as described as in Figure 1. The data presented show the number
of lacZ-forming units per milliliter for each virus in the control and cells
expressing TRIMCyp factors. The error bars represent the mean
measurement ± SD.
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likely putting back the existence of lentiviruses and their associ-
ation with mammalian genomes millions of years. However,
perhaps more surprising is the finding that the interaction of
the lentiviral capsid with cyclophilin appears to be a feature of
ancient lentiviruses.
Until recently, studies of the interaction of CypA and TRIMCyp
factors with the lentiviral capsid have been almost entirely
focused on HIV-1. In fact, CypA has been demonstrated to
bind to the CA-NtD of FIV (Lin and Emerman, 2006) and weakly
to HIV-2 (Price et al., 2009). Moreover, omTRIMCyp restricts
SIVagm and FIV as well as HIV-1, while rhTRIMCyp restricts
FIV, SIVagm, and HIV-2 (Virgen et al., 2008; Wilson et al., 2008),
and the cyclophilin domain binds tightly to the HIV-2 CA-NtD
(Price et al., 2009). Our data now show that this repertoire
of CypA-CA interactions likely extends much further, as the
CA-NtDs of both RELIK and PSIV bind CypA. Moreover,
a remarkable diversity in the nature of the CypA-CA interaction
is revealed. In RELIK, the interaction is mediated through a
CypA-binding loop, similar to that observed in HIV-1. However,
the position of the cis-trans Gly-Pro bond is permuted along
the CypA-binding loop, allowing further interaction of CypA
with secondary sites on the CA-NtD. In PSIV, the loop is much
shorter and contains Gln-Pro rather than Gly-Pro dipeptides.
Similarly, in FIV an Arg-Pro dipeptide is required for CypA binding
(Lin and Emerman, 2006), suggesting there are different
modes of CypA binding that accommodate dipeptides other
than Gly-Pro.
Examination of CA-CypA structures reveals that the interac-
tion largely relies on main chain-side chain interactions between
CypA and the target CA-NtD Cyp loop. However, our observa-
tions now suggest that binding site position, recognition mode,
and alterations in CypA structure (Price et al., 2009) can combine
to produce a large number of variations of the CypA-CA-NtDCell Host &interaction. The existence of so many variations of the CA-
CypA interaction is intriguing, but one possibility is that it relates
to a lentiviral requirement to maintain binding capacity for CypA
or a related molecule while having to evade restriction by
TRIM5a or TRIMCyp. Site permutation and mode switching
provides a mechanism that can continually maintain but alter
the molecular details of the CA-CypA interaction. In this way,
an interaction with a monomeric CypA can be facilitated, and a
more structurally constrained multimeric interaction with a
restriction factor can be discriminated against.
Coevolution of Lentiviruses and Host Defenses
It is now clear that lentiviruses and their vertebrate hosts have
long been involved in an evolutionary arms race extending
back in time for millions of years, long predating the appearance
of HIV-1 (Emerman and Malik, 2010). Presumably in response to
a series of infections by unknown retroviruses, a number of host
restriction factors, including APOBEC3(F-H), tetherin, and
TRIM5a, have appeared and show evidence of rapid genetic
change (Sawyer et al., 2005). It has been suggested that the
need to prevent movement of ERVs might have provided the
selective forces responsible for restriction factor evolution
(Kaiser et al., 2007). However, protection against exogenous
viruses also seems likely to have been of great importance
(Emerman andMalik, 2010). Certainly, CypA-binding lentiviruses
of the type that gave rise to RELIK and PSIV might have been
factors in the independent evolution of omTRIMCyp and
rhTRIMCyp (Stoye and Yap, 2008). In apparent response to the
appearance of host restriction factors, lentiviral proteins Vif
and Nef/Vpu, designed to neutralize APOBEC and tetherin,
respectively, have evolved (Malim and Emerman, 2008).
However, viral accessory proteins directed against the CA
binding factors, TRIM5a, omTRIMCyp, and rhTRIMCyp, have
not been identified. Instead, changes in the capsid sequence
are sufficient to evade restriction, consistent with the positive
selection observed in regions of the B30.2 domain of TRIM5a
(Sawyer et al., 2005).
TRIM5a binding of its viral target is still poorly characterized,
although genetic data firmly point to the involvement of the
surface-exposed CypA-binding loop (Kootstra et al., 2003).
However, given that CypA binding itself can alter restriction,
and in the absence of a co-crystal structure of TRIM5a with
a target viral protein or escape mutants selected in the presence
of TRIM5a, our knowledge of the viral target for TRIM5amust still
be considered incomplete. There is clearly extensive variation
within this loop (Towers, 2007), consistent with the notion of
selected change in response to restriction factors, but this is
hard to quantify, given the sequence differences in conserved
regions of the protein. Nevertheless, despite the apparent
need for variation in this region and the selective pressures
associated with the evolution of TRIMCyp restriction factors,
the ability to bind CypA or related molecules has been retained
for millions of years, suggesting a significant growth advantage
associated with this property.
Potential Roles for Cyclophilin Binding
Since the discovery of CypA binding to Gag, there has been
speculation about its functional significance in virus replication
(Luban et al., 1993). Possible roles include involvement in virionMicrobe 8, 248–259, September 16, 2010 ª2010 Elsevier Inc. 255
Cell Host & Microbe
Structure of the RELIK-CypA Complexassembly, CA uncoating, or protection from the action of
restriction factors (Hatziioannou et al., 2005; Li et al., 2009;
Luban, 1996; Towers et al., 2003). Our finding that cyclophilin
binding is a property of lentiviruses extant over ten million years
ago, in addition to current viruses such as FIV and HIV-1, adds
weight to such a concept. Moreover, the possibility that binding
is not confined to CypA but extends to a variety of cyclophilin
domains (Braaten and Luban, 2001) adds to the number of
potential roles that the binding loop might play. One intriguing
possibility is an involvement in nuclear entry. Lentiviruses can
be distinguished from other retroviruses by their ability to infect
nondividing cells, and CA may be important in allowing the
preintegration complex entry into the nuclei of nondividing cells
(Lee et al., 2010; Yamashita et al., 2007). Potentially, this could
be mediated in part by bound cyclophilins, for example, one of
those present in spliceosomes (Mesa et al., 2008). Alternatively,
this might include the nuclear pore component, RANBP2,
a protein already implicated in HIV-1 nuclear transport in siRNA
experiments (Bushman et al., 2009).
EXPERIMENTAL PROCEDURES
Sequence Analysis and Construction of Synthetic Genes
for RELIK and PSIV CA
To estimate the ancestral sequence of the RELIK family, a maximum likelihood
(ML) approachwas employed. First, aML phylogenetic tree was reconstructed
using PAUP (Swofford, 2003) from the set of proviruses in Katzourakis et al.
(2007). The ML phylogeny was midpoint rooted, and the nucleotide sequence
of the root node was estimated using PAML (Yang, 1997). We applied a
correction to this sequence to account for the effect of methylation-induced
mutations at CpG islands (Cantrell et al., 2008). We considered all dinucleotide
positions in the alignment where the majority was either CG or TG in the
forward strand, and where the majority of taxa contained a TG but at least
one CG was present, the TG state was assumed to have resulted from
methylation-induced mutation, and the ancestral state of the character was
reset to CG. The equivalent procedure was employed in the reverse strand.
The resulting nucleotide sequence was translated in order to obtain an
estimate of the ancestral protein (Figure S5). A codon where methylation-
induced mutation had induced an amino acid change is highlighted in red.
The reversal of TpG to the ancestral CpG at the second position of this codon
led to an inferred ancestral alanine rather than a valine at this position. The
PSIV sequence represents a consensus between closely related sequences
found in the gray mouse and fat-tailed dwarf lemurs (Gilbert et al., 2009).
Chemically synthesized codon-optimized DNA sequences encoding the
RELIK and PSIV capsids were then purchased from Geneart (Regensburg,
Germany) and Genescript (Piscataway, NJ), respectively (Figure S5).
Chimeric Plasmid Constructs
RELIK and PSIV capsids flanked by EIAV sequences were made by overlap-
ping PCR and inserted as BbvCI-PshAI fragments into the EIAV Gag-Pol
plasmid pONY3.1 (Mitrophanous et al., 1999). Sequences of primers used in
these PCR reactions are tabulated in Table S2. For RELIK, the primer pairs
PONYFBbvCI/EIAVRELIKRev2 (PCR-1), EIAVRELIKF3/EIAVRELIKRev4
(PCR-2), and EIAVRELIKF5/PONYRev (PCR-3) were used in initial reactions,
employing pONY3.1, RELIK-CA, and pONY3.1 as templates. Fragments
PCR-1 and PCR-2 were then used as templates in a PCR with
PONYFBbvCI/EIAVRELIKRev4 primers. The resulting fragment was then
combined with the PCR-3 fragment, and a final PCR was carried out using
primer pair PONYFBbvCI/PONYRev. Similarly, the fragment containing the
PSIV capsid was made using primer pairs PONYFBbvCI/EIAVPSIVRev2
(PCR-1), EIAVPSIVF3/EIAVPSIVRev4 (PCR-2), and EIAVPSIVF5/PONYRev
(PCR-3) in initial reactions with pONY3.1, PSIV-CA, and pONY3.1 as
templates. The final fragments from these reactions were then used to replace
the BbvCI-PshAI fragment in pONY3.1, and the resulting constructs were
called pEAIV-RELIK and pEIAV-PSIV, respectively.256 Cell Host & Microbe 8, 248–259, September 16, 2010 ª2010 ElsrhTRIMCyp was cloned from LLCMK2 cells. Briefly, mRNA was extracted
using the Oligotex Direct mRNA kit (QIAGEN), and the gene was amplified
by RT-PCR. The PCR fragment was inserted into pENTR/D-Topo and
transferred to pLGatewayIRESEYFP by LR clonase reaction, resulting in
pLMacT5CIRESEYFP. The construction of pLOMKT5CIRESEYFP has been
previously described (Nisole et al., 2004).
Cells and Viruses
CrFK, SIRC, HT1080, and 293T cells were maintained in DMEM containing
10% fetal calf serum and 1% penicillin/streptomycin. EIAV and chimeric
viruses were made by the transient transfection of 293T cells with pVSVG,
pONY8.4ZCG, and either pONY3.1 (EIAV), pEIAV-RELIK, or pEIAV-PSIV.
HIV-1 and MLV were prepared in a similar manner with pVSVG and either
pWPTS-nlsLacZ plus p8.91 or pHIT111 and pHIT60, respectively. Chimeric
viruses were concentrated by ultracentrifugation at 50,0003 g in a SW28 rotor
for 2 hr. Delivery viruses were made by transfecting 293T cells with pVSVG,
pHIT60, and either pLOMKT5CIRESEYFP or pLMacT5CIRESEYFP and frozen
in aliquots at 80C. Other viruses were used on the day of harvest.
Infectivity and Restriction Assay
The relative infectivity of EIAV and chimeric viruses was assessed in CrFK,
D17, SIRC, and HT1080 cells. Viruses were serially diluted in DMEM, and
1 ml of each dilution was used to infect 53 104 cells in wells of a 12-well plate
in the presence of 10 mg/ml polybrene. Three days postinfection, the cells were
fixed and stained for b-galactosidase (Soneoka et al., 1995). Blue cells were
counted under the microscope for two successive dilutions (with 5–500 blue
cells); input titers were determined by multiplying these numbers by the
dilutions used and expressed as the number of lacZ-forming units per milliliter
of input virus. For experiments employing nondividing cells, D17 cells were
plated at a density of 13 105 cells per well. After cells had attached, aphidico-
lin was added to 15 mg/ml to arrest the cells in S phase; cells were cultured for
24 hr before transduction and maintained at 15 mg/ml aphidicolin throughout
the experiment. Control cells, with no added aphidicolin, were initially plated
at 5 3 104 cells per well. Three days postinfection, the cells were fixed and
stained for b-galactosidase. Cell-cycle arrest was verified by propidium iodide
staining followed by FACS analysis. For assessment of restriction, omTRIM-
Cyp and rhTRIMCyp genes were introduced into CrFK cells by retroviral
vectors carrying the TRIMCyp and YFP genes. About 90% of the cells were
transduced, as determined by FACS. The viral titer was determined as
described.
Viral Protein Analyses
Viruses were harvested in 3 ml EX-CELL 293 serum-free media (Sigma) and
filtered (0.45 mm) before pelleting through a 1.2 ml 20% (w/v) sucrose cushion
at 120,000 3 g for 3 hr in a SW55Ti rotor. Pellets were washed once with PBS
and dissolved in 50 ml SDS loading buffer, and the viral proteins were resolved
by SDS-PAGE. Bands were either stained with imperial protein stain (Pierce) or
blotted onto PVDF membrane (19 V, 100 min). For western analysis, the
membrane was blocked with 5% milk powder at 4C overnight and probed
with a monoclonal anti-VSV-G antibody and a rabbit anti-CypA antibody
(Enzo Life Science; Exeter, UK). Bands were visualized by enhanced chemilu-
minescent detection employing HRP-conjugated anti-mouse and anti-rabbit
secondary antibodies.
Expression Constructs
TheDNA sequences coding for the RELIKCA (residues P1-M225) and PSIVCA
(residues P1-A220) were synthesized, codon optimized, for E. coli expression
(Geneart). The sequences coding for CA amino-terminal domains (RELIK,
P1-S140; PSIV, P1-P134) were then inserted between the NdeI and XhoI sites
of pET22b (Merck; Darmstadt, Germany) to produce C-terminal his-tag fusion
proteins. FIV was similarly cloned using provirus as a PCR template. All
constructs were verified by DNA sequencing. Proteins were expressed in
E. coli BL21 (DE3) and purified using Ni-NTA affinity and size-exclusion
chromatography. CypA was cloned into pGEX-6P1 using EcoRI and XhoI
restriction sites to produce a GST fusion with a 3C protease cleavage site.
GST-CypA was expressed in E. coli BL21 (DE3) and purified by affinity
chromatography, 3C cleavage, and size-exclusion chromatography. Biotiny-
lated CypA (CypA-bio) was produced by addition of a C-terminal BirAevier Inc.
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expressed on plasmid pBirA (Avidity; Aurora, CO). CypA-bio was purified as
described for CypA. B-MLV CA-NtD was expressed and purified as described
previously (Mortuza et al., 2008). The correct processing of the proteins and
incorporation of biotin was verified by ESI-MS.
Protein Crystallization and Structure Determination
The N-terminal domain of RELIK was crystallized in 16%–26% PEG3350,
0.1 M Na-acetate (pH 4.6). Crystals were transferred into cryoprotectant con-
taining 20% glycerol and flash frozen in liquid nitrogen. X-ray data were
collected at Diamond Light Source (Didcot, UK) beamline I0.4 to a resolution
of 1.5 A˚ and processed using the HKL program package (Otwinowski and
Minor, 1997).
The RELIK structure was determined by molecular replacement in PHASER
(McCoy et al., 2007) using the EIAV CA-NtD (1EIA) as a search model. Two
molecules were placed in the asymmetric unit with a final Z score of 23.1.
This model was then rebuilt in Arp/Warp (Morris et al., 2003). Subsequent
iterative rounds of refinement and model building in PHENIX (Zwart et al.,
2008) and COOT (Emsley and Cowtan, 2004) resulted in final Rwork and Rfree
of 19.5% and 21.8%, respectively. TLS was incorporated with 16 separate
TLS groups (8/monomer).
The N-terminal domain of the PSIV capsid was crystallized in 24%
PEG6000, 0.1 M Na-acetate (pH 4.6). Crystals were transferred to cryoprotec-
tant containing 20% glycerol and flash frozen in liquid nitrogen; X-ray data
were collected on a Rigaku Micromax-007HF with a Raxis-IV detector to
a resolution of 2.0 A˚. X-ray diffraction data were processed using the HKL
program package. The structure of PSIV was determined by molecular
replacement in PHASER using the RELIK-NtD as a model. A single molecule
was present in the asymmetric unit (Z score 5.6, LLG 91). The model was
rebuilt using Arp/Warp followed by iterative rounds of refinement and model
building in PHENIX and COOT. Eight TLS groups were included in the
refinement, resulting in a final model with Rwork and Rfree of 18.4% and
22.4%, respectively.
Crystals of RELIK-NtD/CypA were grown in 16%–26% PEG3350, 0.1 M
HEPES (pH 7.5) from a 1:1 mixture of 300 mM RELIK-NtD and 300 mM CypA.
X-ray data were collected using our home source to a resolution of 1.8 A˚
and processed using the HKL program package. The structure was
determined by molecular replacement in PHASER using CypA from the
HIV/CypA complex (1M9C) and the RELIK-NtD structure (2XGU) as search
models. The asymmetric unit consists of a single complex. The model was
rebuilt using Arp/Warp and refined using PHENIX. Manual model building
was carried out in COOT. Refinement resulted in final Rwork and Rfree
factors of 15.6% and 18.7%, respectively. TLS refinement was included with
18 separate groups.
Isothermal Titration Calorimetry
ITC was carried out using an ITC-200 calorimeter (GE Healthcare; Little
Chalfont, UK). Briefly, protein samples were prepared by dialysis against
25 mM Na-phosphate (pH 6.55), 100 mM NaCl, 0.5 mM TCEP. A typical
experiment involved 20 injections of 1–1.5 mM capsid amino-terminal domain
in the injection syringe into 100 mM CypA in the sample cell. Data were
analyzed using the Origin-based software provided by the manufacturers.
Biacore
The interaction of CypA with CA-NtDs was quantitated using a Biacore
2000 biosensor employing streptavidin-coated sensor chips. Single-site
biotinylated CypA (0.1 mg/ml) was bound onto the chip with a 50 ml injection
at 10 ml/min. All binding experiments were carried out in 25 mM Na-phos-
phate (pH 6.55), 100 mM NaCl, 1 mM TCEP, 0.005% P20 with 25 ml injec-
tions of CA-NtD at a flow rate of 50 ml/min. Serially diluted CA-NtD at
concentrations between 1 mM and 0.25 mM were used. All experiments
were performed in triplicate. Data were baseline corrected for 60 s prior to
injection, and a blank channel with no CypA bound was subtracted to
account for refractive index changes. The signal at equilibrium was averaged
over 25 s to give the response. Equilibrium KA were determined in SedPhat
(Vistica et al., 2004) using averaged response values from the three
experiments.Cell Host &ACCESSION NUMBERS
The coordinates and structure factors of PSIV-NtD, RELIK-NtD, and
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